Reliant Technologies, Inc. B remarket Notification:
f
co 4 143 { q Reliant Laser U System and Accessories,
MAR 1 0 2005 Laheling Change
I. 510(k) SUMMARY OF SAFETY AND EI FECTIVENESS
REGULATORY AUTHORITY
| Safe Medical Devices Act of 1990, 21 CFR $07.92
COMPANY NAME/CONTACT
Heather Tanner
Reliant Techaologies, Inc.
260 Sheridan Ave.
Palo Alto, CA 94306
650 473-0200, 103
650 473-0537 fax
htanner@rcliant-tech.com
NAME OF DEVICE
ot Trade Name: Reliant Laser LI System and Accessories (l’raxel SR
Laser System)
Common Namc: Laser Surgical Instrument
: Regulation Number 878.4810
Praduct code: GEX
Device Panel: General Surgcry/Restorative Devices
Device Classification: Class 1
PREDICATE DEVICES
Name: Reliant Laser System HU
510(k) #: K040617
Name: Reliant 1ascr System
510(k) #: K031795
Name: Lumenis UltraPulse Encore
Carbon Dioxide Surgical Laser
and Delivery Device Accessorics
510(k) #: KO22060

Reliant Technologies, Inc. , Premarket Notification:
t oY 2 4 (7 Z { Z Reliant Laser Uf System and A ceessories,
Labeling Change
DEVICE DESCRIPTION
The Reliant laser System Tl consists of a set of fiber lasers, controlled by an embedded
processor, to be used in dermatology. The lascr system uses scanning dnd focusing optics
to deliver a pattern of thermal cnergy to the cpidermis and upper dermig. Device
accessories include tip attachments and pre-treatment solution.
INDICATION FOR USE STATEMENT
The Reliant Laser System 1! is intended for use in:
Dermatological procedures rcquiting the coagulation of sofl tissue;
Treatment of periorbital wrinkles;
Photocoagulation of pigmented lesions, such as, but not limited to lentigps (age spots),
solar lentigos (sun spots) and dyschromia;
.4 Skin resurfacing procedures.
SUBSTANTIAL EQUIVALENCE COMPARISON
‘Technological Characteristics
‘There has becn no change to the Reliant fechnologics Laser System Tl. The system is
identical to the Reliant Technologics 510(k)s cleared under 510(k) K031 95 and
K040617.
{ndications for Use
Substantial equivalence for the Reliant Laser IT System is supported by the predicate
devices listed in this submission, which have identical or similar indication statements.
Clinical Performance Data
“linical analysis was conducted on Non-Significant Risk and IDE Reliant}studies to
support the change in the language in the indications for use statement. 5 fficient safely
nnd efficacy data has been gathered to determine thal the Reliant Laser Il $ystem
berforms as clinically intended and that no new issues of safety and effectiveness are
ntroduced.

Reliant Technologies, Inc. 64 ZR / Premarket Notification:
Reliant Laser U System and Accessories,
Labeling: Change
CONCLUSION
Based on the design, materials, function, intended use and clinical evalhation, the Reliant
Laser {1 System and Accessones is substantially equivalent to the devides currently
marketed under the Federal Food, Drug and Cosmetic Act. Satety and effectiveness arc
reasonably assured, justifying 510(k) clearance. No changes are being nade im the laser
or accessories. The icchnical, mechanical, performance, and clectrical berformance data
submitted in the Reliant ‘Uechnologics cleared 510(k)s are valid, and unaffected by this
change in labeling.
f

en
£ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
i” —e Ue
ee Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
MAR 1 0 2005
Ms. Heather Tanner
Clinical Research/Regulatory Affairs Manager
Reliant Technologies, Inc.
260 Sheridan Avenue, Suite 309
Palo Alto, California 94306
Re: K042319
Trade/Device Name: Reliant Laser System II and Accessories (Fraxel SR Laser System)
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: Il
Product Code: GEX
Dated: December 7, 2004
Received: December 10. 2004
Dear Ms. Tanner:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. ,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. 1 he
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class Il (Special Controls) or class HII (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including. but not limited to: registration and listing (2)
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as sct
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Heather Tanner
This letter will allow you to begin marketing your device as described in your Section 51 0(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/industry/support/index. hunt.

Sincerely yours.

Aled, “ih Tt
aff af Men —
<~ . s
| Miriam C. Provost, Ph.D. .
/ Acting Director
Division of General. Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

Indications for Use
40(k) Number (if known):_K042319
evice Name:___Reliant Laser System Il and Accessories (Fraxel SR Laser System
Indications For Use:
“The Reliant Laser System {! is intended for use in:
Dermatological procedures requiring the coagulation of soft tigsue:
Treatment of periorbital wrinkles;
Photocoagulation of pigmented lesions, such as, but not limited to lentigos (age
spots), solar lentigos (sun spots) and dyschromia;
Skin resurfacing procedures.”
Prescription Use VY AND/OR Over-The-Counter Use
(PBrt 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
N#EDED)
ee
Concurrence of CARH, Office of Device Evaluation (ODE)
y
Aled, Ah.
Mt ene
(Division Sign-Off)
Division of General, Resiorative.
and Neurological Devices
5 i325] q
510(k) Number__KO% 221 1

